Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study

Diabetologia

Volumn 46, Issue 5, 2003, Pages 674-682

  Soedamah Muthu, S S ^b,e   Chang, Y F ^b,c   Otvos, J ^d   Evans, R W ^b   Orchard, T J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d LIPOSCIENCE INC   (United States)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Coronary artery disease; Lipids; Lipoproteins; Nuclear magnetic resonance spectroscopy; Type 1 diabetes mellitus

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANGINA PECTORIS; ARTICLE; CASE CONTROL STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MASS; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

EID: 0037677153     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1094-8     Document Type: Article

References (50)

1. Portuese E, Orchard T (1995) Mortality in insulin-dependent diabetes. In: Diabetes in America, pp 221-232
2. Dullaart RP (1995) Plasma lipoprotein abnormalities in type 1 (insulin-dependent) diabetes mellitus. Neth J Med 46:44-54
3. The DCCT Research Group (1992) Lipid and lipoprotein levels in patients with IDDM diabetes control and complication. Trial experience. The DCCT Research Group. Diabetes Care 15:886-894
4. Taskinen MR (1990) Hyperlipidaemia in diabetes. Baillieres Clin Endocrinol Metab 4:743-775
5. Lahdenpera S, Groop PH, Tilly KM et al (1994) LDL subclasses in IDDM patients: relation to diabetic nephropathy. Diabetologia 37:681-688
6. Jensen T, Stender S, Deckert T (1988) Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 31:142-145
7. Jensen T, Borch JK, Kofoed EA, Deckert T (1987) Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30:144-148
8. Laakso M, Pyorala K, Sarlund H, Voutilainen E (1986) Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus. Arteriosclerosis 6:679-684
9. Reckless JP, Betteridge DJ, Wu P, Payne B, Galton DJ (1978) High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br Med J 1:883-886
10. Rivellese A, Riccardi G, Romano G et al. (1988) Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation. Diabetologia 31:884-888
11. Bagdade JD, Subbaiah PV (1989) Whole-plasma and high-density lipoprotein subfraction surface lipid composition in IDDM men. Diabetes 38:1226-1230
12. Lamarche B, Tchernof A, Moorjani S et al. (1997) Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 95:69-75
13. Gardner CD, Fortmann SP, Krauss RM (1996) Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 276:875-881
14. Austin MA, Breslow JL, Hennekens CH et al. (1988) Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260:1917-1921
15. Katzel LI, Coon PJ, Busby MJ et al. (1992) Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. Arterioscler Thromb 12:814-823
16. Cheung MC, Brown BG, Wolf AC, Albers JJ (1991) Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res 32:383-394
17. Otvos JD Measurement of Lipoprotein subclass profile by nuclear magnetic resonance spectroscopy. Clin Lab 48:171-180
18. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM (1992) Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 38:1632-1638
19. Lyons TJ, Zheng D, Otvos JD et al. (2000) Nuclear Magnetic Resonance (NMR)-Determined lipoprotein subclass profile in the DCCT/EDIC Cohort: associations with retinopathy and nephropathy. Diabetes 49:A269
20. Colhoun HM, Otvos JD, Rubens MB et al. (2002) Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes. Diabetes 51:1949-1956
21. Orchard TJ, Dorman JS, Maser RE et al. (1990) Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116-1124
22. Wagener DK, Sacks JM, LaPorte RE, Macgregor JM (1982) The Pittsburgh study of insulin-dependent diabetes mellitus. Risk for diabetes among relatives of IDDM. Diabetes 31:136-144
23. Hypertension detection and follow-up program cooperative group (1976) The hypertension detection and follow-up program: hypertension detection and follow-up program cooperative group. Prev Med 5:207-215
24. Bucolo G, David H (1973) Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19:476-482
25. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475
26. Warnick GR, Albers JJ (1978) A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 19:65-76
27. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
28. Cruickshanks KJ, Orchard TJ, Becker DJ (1985) The cardiovascular risk profile of adolescents with insulin-dependent diabetes mellitus. Diabetes Care 8:118-124
29. Mendoza SG, Zerpa A, Carrasco H et al. (1983) Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. Artery 12:1-23
30. Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ (2000) Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49:626-632
31. Otvos JD, Jeyarajah EJ, Bennett DW (1991) Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem 37:377-386
32. Redgrave TG, Carlson LA (1979) Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man. J Lipid Res 20:217-229
33. Grundy SM, Vega GL, Otvos JD, Rainwater DL, Cohen JC (1999) Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence. J Lipid Res 40:229-234
34. Blake GJ, Otvos JD, Rifai N, Ridker PM (2002) Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation 106:1930-37
35. Rumsey SC, Galeano NF, Arad Y, Deckelbaum RJ (1992) Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins. J Lipid Res 33:1551-1561
36. Klein R, Klein BE, Moss SE (1989) The Wisconsin epidemiological study of diabetic retinopathy: a review. Diabetes Metab Rev 5:559-570
37. Ellis D, Buffone GJ (1977) New approach to evaluation of proteinuric states. Clin Chem 23:666-670
38. Maser RE, Steenkiste AR, Dorman JS et al. (1989) Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 38:1456-1461
39. The DCCT Research Group. (1988) Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes 37:476-481
40. Koivisto VA, Stevens LK, Mattock M et al. (1996) Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care 19:689-697
41. Fuller JH, Stevens LK, Wang SL (2001) Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia 44 [Suppl 2]:S54-S64
42. Forrest KY, Becker DJ, Kuller LH, Wolfson SK, Orchard TJ (2000) Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 148:159-169
43. Freedman DS, Otvos JD, Jeyarajah EJ et al. (1998) Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 18:1046-1053
44. Karpe F, Hellenius ML, Hamsten A (1999) Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease. Metabolism 48:301-307
45. Ebenbichler CF, Kirchmair R, Egger C, Patsch JR (1995) Postprandial state and atherosclerosis. Curr Opin Lipidol 6:286-290
46. Hokanson JE, Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3:213-219
47. Erbey JR, Robbins D, Forrest KY, Orchard TJ (1999) Low-density lipoprotein particle size and coronary artery disease in a childhood-onset type 1 diabetes population. Metabolism 48:531-534
48. Brewer HB (1999) Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease. Am J Cardiol 83:3F-12F
49. Decossin C, Castro G, Derudas B et al. (1997) Subclasses of LpA-I in coronary artery disease: distribution and cholesterol efflux ability. Eur J Clin Invest 27:299-307
50. Otvos JD, Shalaurova I, Freedman DS, Rosenson RS (2002) Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial. Atherosclerosis 160:41-48